Telangana: ICMR- NIN begins 4th round of serosurvey in state’s districts; check details

By: |
June 23, 2021 5:10 PM

ICMR-NIN: While the last serosurvey was conducted last year in December 2020 on adolescents between the age group of 10-17 year old, the latest one will include children in the age group 6 to 9 years.

Telangana, COVID 19, ICMR-NINOn Wednesday, Telangana recorded 1, 175 new COVID-19 cases taking the tally to over 6.16 lakh while the death toll stood at 3,586 with 10 fresh deaths (File Photo: PTI)

Telangana : In an effort to gauge the spread of COVID-19 , The Indian Council of Medical Research-National Institute of Nutrition and the Telangana government has begun the fourth round of serosurvey in Jangaon, Kamareddy, and Nalgonda districts of the state on Tuesday. While the last serosurvey was conducted last year in December 2020 on adolescents between the age group of 10-17 year old, the latest one will include children in the age group 6 to 9 years. The other two surveys before that took place in May and August in 2020. The surveys included healthcare workers as well for over 18 years of age. These serosurveys are done from time to time in order to study the extent of virus spread.

Although the number of coronavirus cases in Telangana is somewhat under control, the study still holds the importance as health experts have flagged possibility of third wave of COVID-19 infection which is most likely to hit in 6-8 weeks if people fail to address to covid appropriate behaviour.

According to Dr A Laxmiah, who is the head of the Public Health Division at ICMR-NIN and the coordinator of the survey, this is the fourth in the serial cross-sectional surveys. The survey will cover about 400 subjects from 10 villages of each of the three districts (Jangaon, Kamareddy, and Nalgonda) in the state. Also, 100 healthcare workers from district hospitals and community health centers would be a part of this.

The sero-epidemiological studies will help determine the spread of COVID-19 at the community level. Dr R Hemalatha, Director, ICMR-NIN, in a statement said that for this purpose, we are actively working in collaboration with the Telangana government. We are happy that the state health department and the district authorities have ensured that the surveillance takes place smoothly, she added.

The survey-based data will be collected within two to three days. The IgG (ImmunoglobulinG) antibody-based seropositivity indicates the extent of infection spread in the population in general. This will further help in understanding transmission trends of SARS-CoV-2 infection in the general population and frontline workers. And this will further help form the strengthening measures for the upcoming spike in COVID infections, the experts said.

The results of the third round of serosurvey conducted by NIN in December last year suggested that 24.1 per cent of all samples collected had tested positive for antibodies, which means one in every four people had contracted the virus already. As per the results of the first round of serosurvey in May 2020, the percentage of infection stood at 0.33 per cent. And with the second round of survey, which took place in August last year, the percentage of prevalence rose to 12.5 per cent.

On Wednesday, Telangana recorded 1, 175 new COVID-19 cases taking the tally to over 6.16 lakh while the death toll stood at 3,586 with 10 fresh deaths.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
167.6 pc population above 6 years found to have Covid antibodies in 4th national serosurvey, Lok Sabha told
2Bharat Biotech commits to supply 500 Mn doses of Covaxin to Centre for immunisation programme
3Over 2.75 crore unutilised vaccine doses still available with states, private hospitals: Govt